Schrödinger is a scientific software and biotechnology company that has pioneered a physics-based computational platform to accelerate drug discovery and materials design. The company's platform enables the rapid and accurate discovery of high-quality, novel molecules. Schrödinger licenses its software to biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide, and also leverages the platform to advance its own portfolio of collaborative and proprietary drug discovery programs.